Steroid Diabetes in Patients With Kidney Disease
- Conditions
- Nephrotic Syndrome
- Interventions
- Other: no intervention
- Registration Number
- NCT06161701
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Brief Summary
If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.
- Detailed Description
1. Patients with nephrosis who had taken glucocorticoid for the first time were followed up, and those who had diabetes themselves were excluded.
2. Regularly follow up and record information on glucocorticoid medication, medications that have an impact on blood sugar, fasting blood sugar, 2-hour postprandial blood sugar, and glycated hemoglobin.
3. Notify relevant doctors of any cases of elevated blood sugar.
4. The total follow-up time is 1 year.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 300
- Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus；
- Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone；
- Patients with diabetes；
- Those who are unable to communicate through language；
- Uremic patients；
- Unable to perform blood glucose monitoring and follow-up as required；
- Those who have used glucocorticoids within the past 3 months and have accumulated a dose of 10mg or more of prednisone；
- Participated in other clinical studies。
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Blood glucose management in patients with kidney disease after using glucocorticoids no intervention Blood glucose monitoring for kidney disease patients after taking glucocorticoids
- Primary Outcome Measures
Name Time Method Incidence of steroid diabetes in nephrotic patients after glucocorticoid use If the use of glucocorticoids exceeds one year, observe for one year; If the usage time is less than one year, observe 3 months after discontinuation of medication. steroid diabetes is defined as the absence of diabetes in the past, which occurs after the use of glucocorticoid:
1. Typical symptoms accompanied by any of the following:
Fasting blood glucose ≥ 7.0mmol/L or random blood glucose ≥ 11.1mmol/L or plus OGTT 2-hour blood glucose ≥ 11.1mmol/L; Or glycated hemoglobin is greater than or equal to 6.5%;
2. If there are no typical symptoms, then it needs to meet any two or more of the above results;
The incidence of steroid diabetes is defined as the number of patients diagnosed with steroid diabetes after glucocorticoid use/the number of patients enrolled \* 100%
- Secondary Outcome Measures
Name Time Method Cumulative use time of glucocorticoid, cumulative dose of glucocorticoid and drugs that may affect blood glucose in combination with steroid diabetes Time from enrollment to steroid diabetes happens The cumulative use time of glucocorticoid refers to the time from regular use of glucocorticoid to steroid diabetes;
The cumulative dose of glucocorticoid refers to the cumulative dose of glucocorticoid from the time of regular use of glucocorticoid to the time of occurrence of steroid diabetes, calculated by prednisone;
Medications that may affect blood sugar in combination therapy: Tacrolimus, cyclosporine, hydrochlorothiazide β- Receptor blockers, etc.
Trial Locations
- Locations (1)
Zhejiang provincial people's hospital
🇨🇳Hangzhou, Zhejiang, China